🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ximo Pechuan-Jorge

Revolution Medicines (United States)

ORCID: 0000-0001-8938-7931

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load”.

Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load

Blood Advances(2022)10.1182/bloodadvances.2022008834

N/A

1.1DataRank · unranked

36 citations

Junkai Yang, Astrid Kosters, Vincent D. Giacalone, Ximo Pechuan-Jorge, Joshua D. Chandler +14 more

Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS -Mutant Non–Small Cell Lung Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0421

N/A

0DataRank · unranked

67 citations

Ximo Pechuan-Jorge, Teng Zhou, Minh Truong, Xin Hu, Frank Rojas +22 more

A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1425

N/A

0DataRank · unranked

15 citations

Riccardo Mezzadra, Exequiel M. Sisso, Felix Mbuga, Rashi Raghulan, Almudena Chaves Perez +15 more